The comparison of these clusters showed that patients included in Cluster1 presented a better biochemical profile, as proven by a lower incidence of lymphopenia and lower levels of inflammatory and immune activation markers, such as CRP and CD8 + T memory stem cells. This evidence concerns the gene CD8A and lymphopenia.